Cathie Wood's ARK Invest Buys Nearly 475,000 Shares of Signify Health

Investing

Published: December 8, 2021 7:50 am

A couple ARK Invest exchange-traded funds run by ETF star Cathie Wood bought nearly 475,000 shares of Signify Health Inc. (NYSE: SGFY) on Tuesday, as the price of these funds were up more than 5% in Tuesday’s session. These funds had only turned negative recently in their performance over the past year.
[in-text-ad]
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 160,234 shares of Signify Health, and ARK Innovation ETF (NYSEARCA: ARKK) added 313,766 shares. At Tuesday’s closing price, this would have valued thes purchases at roughly $7.2 million. This is only a small fraction of the total holdings. The Genomic Revolution fund is down 32% over the past 52 weeks, and the other is down nearly 16% in the same time.

Check out all the ARK Invest trades for Tuesday:

Fund	Direction	Ticker	Name	Shares
ARKF	Buy	DSYSJ	DISCOVERY	55,621
ARKG	Buy	SGFY	SIGNIFY HEALTH	160,234
ARKG	Sell	TAK	TAKEDA PHARMACEUTICAL	846,189
ARKK	Buy	SGFY	SIGNIFY HEALTH	313,766
ARKK	Buy	TDOC	TELADOC HEALTH	63,567
ARKK	Sell	EDIT	EDITAS MEDICINE	138,796
ARKQ	Buy	BLDE	BLADE AIR MOBILITY	11,926

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.

24/7 Wall St.
6 UBS ‘Strong Buy’ Top Picks Also Pay Big and Dependable Dividends

Cash Back Credit Cards Have Never Been This Good

Credit card companies are at war, handing out free rewards and benefits to win the best customers. A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges. See our top picks for the best credit cards today. You won’t want to miss some of these offers.

Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.